
-
PSG eye becoming France's first 'Invincibles'
-
Late birdie burst lifts Ryder to Texas Open lead
-
Five potential Grand National fairytale endings
-
Trump purges national security team after meeting conspiracist
-
More work for McIlroy even with two wins before Masters
-
Trump hopeful of 'great' PGA-LIV golf merger
-
No.1 Scheffler goes for third Masters crown in four years
-
Where Trump's tariffs could hurt Americans' wallets
-
Trump says 'very close to a deal' on TikTok
-
Trump tariffs on Mexico: the good, the bad, the unknown
-
Postecoglou denies taunting Spurs fans in Chelsea defeat
-
Oscar-winning Palestinian director speaks at UN on Israeli settlements
-
With tariff war, Trump also reshapes how US treats allies
-
Fernandez fires Chelsea into fourth as pressure mounts on Postecoglou
-
South Korea court to decide impeached president's fate
-
Penguin memes take flight after Trump tariffs remote island
-
E.T., no home: Original model of movie alien doesn't sell at auction
-
Italy's Brignone has surgery on broken leg with Winter Olympics looming
-
Trump defiant as tariffs send world markets into panic
-
City officials vote to repair roof on home of MLB Rays
-
Rockets forward Brooks gets one-game NBA ban for technicals
-
Pentagon watchdog to probe defense chief over Signal chat row
-
US tariffs could push up inflation, slow growth: Fed official
-
New Bruce Springsteen music set for June 27 release
-
Tom Cruise pays tribute to Val Kilmer
-
Mexico president welcomes being left off Trump's tariffs list
-
Zuckerberg repeats Trump visits in bid to settle antitrust case
-
US fencer disqualified for not facing transgender rival
-
'Everyone worried' by Trump tariffs in France's champagne region
-
Italy's Brignone suffers broken leg with Winter Olympics looming
-
Iyer blitz powers Kolkata to big IPL win over Hyderabad
-
Russian soprano Netrebko to return to London's Royal Opera House
-
French creche worker gets 25 years for killing baby with drain cleaner
-
UK avoids worst US tariffs post-Brexit, but no celebrations
-
Canada imposing 25% tariff on some US auto imports
-
Ruud wants 'fair share' of Grand Slam revenue for players
-
Lesotho, Africa's 'kingdom in the sky' jolted by Trump
-
Trump's trade math baffles economists
-
Gaza heritage and destruction on display in Paris
-
'Unprecedented crisis' in Africa healthcare: report
-
Pogacar gunning for blood and thunder in Tour of Flanders
-
Macron calls for suspension of investment in US until tariffs clarified
-
Wall St leads rout as world reels from Trump tariffs
-
Mullins gets perfect National boost with remarkable four-timer
-
Trump tariffs hammer global stocks, dollar and oil
-
Authors hold London protest against Meta for 'stealing' work to train AI
-
Tate Modern gifted 'extraordinary' work by US artist Joan Mitchell
-
Mexico president welcomes being left off Trump's new tariffs list
-
Tonali eager to lead Newcastle back into Champions League
-
Lesotho hardest hit as new US tariffs rattle Africa

Katalin Kariko, scientific maverick who paved way for mRNA vaccines
Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.
Now, her pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.
Kariko, 68, spent much of the 1990s writing grant applications to fund her research into "messenger ribonucleic acid" -- genetic molecules that tell cells what proteins to make, essential to keeping our bodies alive and healthy.
She believed mRNA held the key to treating diseases where having more of the right kind of protein can help -- like repairing the brain after a stroke.
But the University of Pennsylvania, where Kariko was on track for a professorship, decided to pull the plug after the grant rejections piled up.
"I was up for promotion, and then they just demoted me and expected that I would walk out the door," she told AFP in an interview from her home in Philadelphia in December 2020.
Kariko didn't yet have a green card and needed a job to renew her visa. She also knew she wouldn't be able to put her daughter through college without the hefty staff discount.
She decided to persist as a lower-rung researcher, scraping by on a meagre salary.
It was a low point in her life and career, but "I just thought...you know, the (lab) bench is here, I just have to do better experiments," she said.
The determination runs in the family -- her daughter Susan Francia did go to UPenn, where she earned a master's degree, and won gold medals with the US Olympic rowing team in 2008 and 2012.
- Twin breakthroughs -
By the late 1980s, much of the scientific community was focused on using DNA to deliver gene therapy, but Kariko believed that mRNA was also promising since most diseases are not hereditary and don't need solutions that permanently alter our genetics.
First though, she had to overcome a major problem: in animal experiments, synthetic mRNA was causing a massive inflammatory response as the immune system sensed an invader and rushed to fight it.
Kariko, together with her main collaborator and co-winner Drew Weissman, discovered that one of the four building blocks of the synthetic mRNA was at fault -- and they could overcome the problem by swapping it out with a modified version.
They published a paper on the breakthrough in 2005. Then, in 2015, they found a new way to deliver mRNA into mice, using a fatty coating called "lipid nanoparticles" that prevent the mRNA from degrading, and help place it inside the right part of cells.
Both these innovations were key to the Covid-19 vaccines developed by Pfizer and its German partner BioNTech, where Kariko is now a senior vice president, as well as the shots produced by Moderna.
Both work by giving human cells the instructions to make a surface protein of the coronavirus, which simulates an infection and trains the immune system for when it encounters the real virus.
- New treatments -
Though she does not want to make too much of it, as a foreign-born woman in a male-dominated field, Kariko occasionally felt underestimated -- saying people would approach after lectures and ask "Who's your supervisor?"
"They were always thinking, 'That woman with the accent, there must be somebody behind her who is smarter or something,'" she said.
Yet the Nobel is just the latest accolade for Kariko, who has won the Breakthrough Prize, the L'Oreal-UNESCO prize for women in science awards, among many others.
It is a far cry from the time when her late mother would call every year after prize announcements to ask why she hadn't been chosen.
"I never in my life get (federal) grants, I am nobody, not even faculty," she would reply with a laugh.
To which her mother would reply: "But you work so hard!"
P.Costa--AMWN